Alzheimer; News from the web:
Professor Peter Nordstrom, of Umea University, Umea, Sweden, and colleagues reviewed records on 7,073 Alzheimer’s patients taking cholinesterase inhibitors (ChEIs), such as Donepezil, Rivastigmine and Galantamine, which are used for treating mild to moderate Alzheimer’s disease.
Prof Nordstrom said: “……It means that for every 100,000 people with Alzheimer’s disease, there would be 180 fewer heart attacks – 295 as opposed to 475 – and 1125 fewer deaths from all causes – 2000 versus 3125 – every year among those taking ChEIs compared to those not using them.” –
Read all about it HERE
visit us at AlzheimerHeadlines.com